Antibody levels stay elevated throughout six months after the second dose of the Moderna COVID-19 vaccine
The Moderna mRNA-1273 vaccine was previously shown to be 94.1% efficacious at preventing COVID-19 illness in a phase 3 trial of 30,420 volunteers.